Radiolabeled Tyrosine Kinase Inhibitors for Drug Development and Cancer treatment: TKI-PET

P. Slobbe

Radiolabeled Tyrosine Kinase Inhibitors for Drug Development and Cancer treatment: TKI-PET

P. Slobbe

Research output: PhD Thesis › PhD Thesis - Research VU Amsterdam, graduation VU Amsterdam

130 Downloads (Pure)

Original language	English
Qualification	PhD
Awarding Institution	Vrije Universiteit Amsterdam
Supervisors/Advisors	van Dongen, G.A.M.S., Supervisor, External person Windhorst, A.D., Supervisor, External person Poot, A.J., Co-supervisor, External person
Award date	17 Nov 2016
Publication status	Published - 2016

Bibliographical note

Geneeskunde
Naam instelling promotie: VU University
Naam instelling onderzoek: VU University medical center

Keywords

Positron Emmission Tomography
PET
Tyrosine Kinase Inhibitors
Personalized Medicine
Cancer
afatinib
erlotinib
vemurafenib
axitinib
nintedanib
radiochemistry

Access to Document

CoverFinal published version, 3.5 MB
Title pageFinal published version, 519 KB
Abstract dutchFinal published version, 620 KB
Abstract englishFinal published version, 610 KB
Table of contentsFinal published version, 538 KB
Complete dissertationFinal published version, 8.01 MB

Cite this

@phdthesis{d24e4528245b4f16ac62d64a51ba6572,

title = "Radiolabeled Tyrosine Kinase Inhibitors for Drug Development and Cancer treatment: TKI-PET",

keywords = "Positron Emmission Tomography, PET, Tyrosine Kinase Inhibitors, Personalized Medicine, Cancer, afatinib, erlotinib, vemurafenib, axitinib, nintedanib, radiochemistry",

author = "P. Slobbe",

note = "Geneeskunde Naam instelling promotie: VU University Naam instelling onderzoek: VU University medical center",

year = "2016",

language = "English",

school = "Vrije Universiteit Amsterdam",

}

TY - THES

T1 - Radiolabeled Tyrosine Kinase Inhibitors for Drug Development and Cancer treatment: TKI-PET

AU - Slobbe, P.

N1 - Geneeskunde Naam instelling promotie: VU University Naam instelling onderzoek: VU University medical center

PY - 2016

Y1 - 2016

KW - Positron Emmission Tomography

KW - PET

KW - Tyrosine Kinase Inhibitors

KW - Personalized Medicine

KW - Cancer

KW - afatinib

KW - erlotinib

KW - vemurafenib

KW - axitinib

KW - nintedanib

KW - radiochemistry

M3 - PhD Thesis - Research VU Amsterdam, graduation VU Amsterdam

ER -